Therapeutic Advances in Urology (Aug 2016)
Optimal treatment of tuberous sclerosis complex associated renal angiomyolipomata: a systematic review
Abstract
Renal angiomyolipomata associated with tuberous sclerosis complex are often bilateral, multiple and progressive. They cause significant morbidity and mortality in older children and adults. Surveillance and pre-emptive treatment reduce this risk. Recent research suggests treatment with mammalian target of rapamycin inhibitors is better at preventing bleeding, recurrence, and preserving renal function than percutaneous embolization.